Table 1 Clinical and biochemical data of the study group
From: Effect of pre and post-transplant body mass index on pediatric kidney transplant outcomes
Mean ± SD/Median (IQR) | Range | |||
|---|---|---|---|---|
Clinical data | ||||
Age (years) | 12.24 ± 3.04 | 5–17 | ||
Episodes of rejection | 3.2 ± 1.4 | 0–6 | ||
Weight (kg) Pre KT | 27.1 ± 10.48 | 12–50 | ||
Weight Pre KT SDS | 0.46 (-0.68 – 1.77) | -5.34- 4.04 | ||
Weight (kg) Post KT | 39.46 ± 14.02 | 22—90 | ||
Weight Post KT SDS | 0.78 ( 0.35 – 2.15) | -2.6 – 4.1 | ||
Height (cm) Pre KT | 115 ± 14.5 | 90- 145 | ||
Height Pre KT SDS | -1.34 (-2.84 – -0.33) | -4.59 – 4.97 | ||
Height (cm) Post KT | 133 ± 17.18 | 95–157 | ||
Height Post KT SDS | -1.49 (-2.31—0.69) | -3.94 -2.49 | ||
BMI Pre KT (kg/m2) | 21.34 ± 4.9 | 10–32 | ||
BMI Pre KT SDS | 1.82 (0.68 – 2.63) | -11.69 – 3.6 | ||
BMI Post KT (kg/m2) | 28.5 ± 6.27 | 19- 48 | ||
BMI Post KT SDS | 2.28 (1.67 – 2.83) | 0.22 – 3.91 | ||
Systolic BP | 121.14 ± 12.8 | 100–150 | ||
Diastolic BP | 77.12 ± 9.2 | 60–95 | ||
Biochemical data | ||||
TGs (mg/dl) | 148.08 ± 72.82 | 62 – 300 | ||
Cholesterol (mg/dl) | 219.9 ± 48.89 | 120 – 330 | ||
HDL (mg/dl) | 52.78 ± 13.65 | 27 – 70 | ||
LDL (mg/dl) | 152.36 ± 30.74 | 70 – 250 | ||
FBG (mg/dl) | 96.35 ± 11.2 | 80–119 | ||
2 h PPBG (mg/dl) | 130.38 ± 27.9 | 83–179 | ||
HbA1c (%) | 5.47 ± 0.45 | 4.8 – 7 | ||
Total (n = 50) | ||||
Number | percentage | |||
Cause of ESRD | ||||
Genetic | FSGS | 8 | 16% | |
Cystinosis | 1 | 2% | ||
Nephronophthisis | 5 | 10% | ||
CAKUT | PUV | 4 | 8% | |
VUR | 9 | 18% | ||
Neurogenic bladder | 4 | 8% | ||
Unknown | Bilateral atrophic kidney | 18 | 36% | |
Malignancy | Wilm’s tumor | 1 | 2% | |